bcbs cover tirzepatide Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden Does Blue Cross Blue Shield
Description
The experience of one 60-year-old woman ("patient 3") is described in the new study, which was published Nov

doi: 10.1016/s0140-6736(94)90571-1
Foundayo is estimated to become an $11.8 billion blockbuster by 2032 (per Evaluate Ltd estimates)

By activating GLP-1 receptors in the brain, Saxenda helps reduce hunger, increase feelings of fullness, and slow gastric emptying, leading to reduced calorie intake and gradual weight loss

In part 2 I discuss the risk factors, side effects and unknowns of using these medications, and in part 3 Ill discuss the benefits and possible pros of taking them
